Global Percutaneous Mechanical Circulatory Support Devices Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

How Big Is the Percutaneous Mechanical Circulatory Support Devices Market Size Expected to Be by 2034?
The market for percutaneous mechanical circulatory support devices has witnessed significant expansion in the preceding years. The market value is set to rise from $2.26 billion in 2024 to $2.48 billion in 2025, with a compound annual growth rate (CAGR) of 10.0%. The growth observed in the historic period can be traced back to factors such as the rising occurrence of cardiovascular diseases, an aging population, an increased rate of heart attacks, heightened awareness and increased screening programs, and the escalating demand for heart pump devices.

In the coming years, robust growth is anticipated in the market for percutaneous mechanical circulatory support devices, with it expected to reach a value of $3.60 billion in 2029, representing a compound annual growth rate (CAGR) of 9.7%. The predicted growth during this period can be linked to several factors like the increased requirement for long-term mechanical circulatory support, escalating healthcare spending, expanding diabetic and obese demographics, the surging need for heart transplants, and a growing acceptance of percutaneous procedures. The forecast period is also anticipated to see key trends shaping the market including improvements in pump technology, progress in medical technology, advancements in cardiac support technologies, the emergence of minimally invasive medical technologies, and the development of biocompatible materials.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20921

What Are the Emerging Segments Within the Percutaneous Mechanical Circulatory Support Devices Market?
The percutaneous mechanical circulatory support devices market covered in this report is segmented -

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp

What Long-Term Drivers Are Shaping Percutaneous Mechanical Circulatory Support Devices Market Trends?
The rise in cardiovascular diseases is anticipated to boost the expansion of the percutaneous mechanical circulatory support devices market. Cardiovascular diseases encompass a range of disorders impacting the heart and blood vessels, inclusive of conditions such as coronary artery disease, heart attacks, heart failure, stroke, and elevated blood pressure. The rising instances of these diseases can be linked to elements like an aging demographic, poor lifestyle habits, obesity, hypertension, and genetic factors. Percutaneous mechanical circulatory support devices are employed in managing cardiovascular diseases to enhance cardiac functioning, alleviate heart stress, and aid recovery during severe heart conditions. For instance, as per the Australian Institute of Health and Welfare, an agency operating under the Australian government, certified deaths due to coronary heart disease rose to 14,100 in 2021 from to 14,900 in 2022. Consequently, the uptick in cardiovascular diseases is fuelling the expansion of the percutaneous mechanical circulatory support devices market.

Who Are the Top Competitors in Key Percutaneous Mechanical Circulatory Support Devices Market Segments?
Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.

What Actigraphy Devices Market Trends Are Gaining Traction Across Different Segments?
Leading companies engaged in the percutaneous mechanical circulatory support devices market are turning their attention to creating advanced solutions like the intra-aortic axial-flow devices. These devices aim to improve patient outcomes and cut down on surgical risks. In a more specific sense, an intra-aortic axial-flow device is a kind of percutaneous mechanical circulatory support device made to enhance heart function by increasing blood flow from the left ventricle to the aorta. For example, in February 2023, a US medical device organization named Procyrion, Inc. declared the effective first use of its Aortix pump in humans. This cutting-edge device is crafted to prevent acute kidney injury in patients facing cardiac surgery. The Aortix pump is introduced through a catheter into the descending thoracic aorta and works to enhance renal perfusion whilst simultaneously lowering the load on the heart during surgery. This device is especially beneficial for patients with compromised left ventricular function and kidney issues as it boosts both renal and systemic perfusion and reduces heart strain. The Aortix pump, with a capacity to deliver up to 5.0 liters of flow per minute, is meant for temporary usage during procedures like percutaneous coronary interventions.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

Which Regions Are Becoming Hubs for Percutaneous Mechanical Circulatory Support Devices Market Innovation?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Percutaneous Mechanical Circulatory Support Devices Market?
2. What is the CAGR expected in the Percutaneous Mechanical Circulatory Support Devices Market?
3. What Are the Key Innovations Transforming the Percutaneous Mechanical Circulatory Support Devices Industry?
4. Which Region Is Leading the Percutaneous Mechanical Circulatory Support Devices Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.